-
Views
-
Cite
Cite
Sara L. Schneider, Vitauts Alks, Charles E. Morreal, Oilip K. Sinha, Thomas L. Dao, Estrogenic Properties of 3,9-Dihydroxybenz[a]anthracene, a Potential Metabolite of Benz[a]anthracene, JNCI: Journal of the National Cancer Institute, Volume 57, Issue 6, December 1976, Pages 1341–1354, https://doi.org/10.1093/jnci/57.6.1351
- Share Icon Share
Abstract
The estrogen receptor binding properties of 3,9-dihydroxybenz[a]anthracene (3,9-diOHBA) were determined in uterine cytosol of immature Sprague-Dawley rats by competitive binding experiments with (3H]estradiol and sucrose density centrifugation. 3,9-DiOHBA inhibited estradiol binding to the 8S binding protein at a concentration (1.2×10−5M) approximately equal to that of nafoxidine-HCI (3×10−5M) required to inhibit estradiolspecific binding, and bioassay for estrogenic activity substantiated this finding.